APA (7th ed.) Citation

E, G., A, E., K, C., D, O., A, D., V, F., . . . B, R. (2026). Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-25-4793

Chicago Style (17th ed.) Citation

E, Gariazzo, et al. "Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC Without Actionable Genomic Alterations Who Never Used Tobacco." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 2026. https://doi.org/10.1158/1078-0432.CCR-25-4793.

MLA (9th ed.) Citation

E, Gariazzo, et al. "Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC Without Actionable Genomic Alterations Who Never Used Tobacco." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 2026, https://doi.org/10.1158/1078-0432.CCR-25-4793.